MCK vs VEEV vs COR Stock Comparison

Mckesson, Veeva Systems and Cencora Prices as of Oct 26, 2026 Peers: Industry group
MCK Mckesson Corp
$992.64 +14.5% 1M +23.8% 1Y
Market cap
$115.52B
P/E
25.2x
Revenue (TTM)
$410.98B
Div. yield
0.00%
Drug Distribution Healthcare
6 wins
VEEV Veeva Systems Inc
$318.21 +13.4% 1M +8.6% 1Y
Market cap
$50.81B
P/E
50.1x
Revenue (TTM)
$3.46B
Div. yield
–
Healthcare IT Technology
3 wins
COR Cencora, Inc.
$330.24 +7.6% 1M -0.7% 1Y
Market cap
$63.25B
P/E
24.1x
Revenue (TTM)
$332.77B
Div. yield
0.01%
Drug Distribution Healthcare
3 wins

Head to Head

12 decided of 12

Mckesson leads on 6 of the 12 questions below (Mckesson 6, Cencora 3, Veeva Systems 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMCKVEEVCORLeader
Larger companyMarket capitalisation $115.52B $50.81B $63.25B MCK
Cheaper on earningsLower P/E, profitable companies only 25.2x 50.1x 24.1x COR
Cheaper on forward earningsLower price / next fiscal year consensus EPS 21.1x 35.5x 19.3x COR
Faster revenue growthRevenue growth, trailing twelve months +8.8% +16.5% +5.1% VEEV
More profitableNet margin, trailing twelve months 1.1% 29.3% 0.8% VEEV
Better return on capitalReturn on invested capital 107.9% — 14.4% MCK
Less leveragedLower net debt / EBITDA 0.6x — 2.2x MCK
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.01% COR
Better 1-year returnPrice return, last 12 months +23.8% +8.6% -0.7% MCK
Better 5-year returnAnnualised price return, 5 years +37.4%/yr +0.3%/yr +22.6%/yr MCK
Less volatileAnnualised volatility, 1 year 30.7% 42.9% 32.8% MCK
Higher overall scoreMean of the five percentile scores vs peers 58/100 68/100 51/100 VEEV

Percentile Scorecard

MCKVEEVCOR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMCKVEEVCOR
Valuation 50 #13 of 25 36 #58 of 90 54 #12 of 25
Growth 65 #9 of 24 74 #22 of 82 74 #7 of 24
Profitability 65 #9 of 24 87 #11 of 77 57 #11 of 24
Financial Health 48 #14 of 26 95 #6 of 96 24 #20 of 26
Shareholder Returns 60 #7 of 16 49 #28 of 54 47 #9 of 16
Overall 58 68 51
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • VEEV ranked among 99 companies in Vertical Software
  • COR ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMCKVEEVCORSPY
1 month +14.5%+13.4%+7.6% -0.8%
3 months +16.7%+63.7%+6.1% +3.5%
6 months +19.8%+98.3%+6.5% +7.0%
Year to date +21.0%+42.5%-2.2% +12.2%
1 year +23.8%+8.6%-0.7% +13.0%
3 years +121.6%+67.9%+76.0% +86.3%
3 years, per year +30.4%+18.9%+20.8% +23.1%
5 years +388.9%+1.5%+176.2% +68.6%
5 years, per year +37.4%+0.3%+22.6% +11.0%
10 years +526.0%+735.4%+316.1% +258.0%
10 years, per year +20.1%+23.7%+15.3% +13.6%

Risk

MeasureMCKVEEVCORSPY
Volatility, 1Y 30.7%42.9%32.8% 12.7%
Downside volatility, 1Y 27.3%40.3%39.6% 12.7%
Beta vs S&P 500, 1Y -0.260.57-0.15 1.00
Return / volatility, 1Y 0.780.20-0.02 1.02
Max drawdown, 5Y -27.2%-52.8%-32.6% -25.4%
From 52-week high -3.6%-1.5%-11.9% -1.8%
52-week high $1,030.18$322.91$374.75 $779.14
52-week low $725.17$151.43$252.74 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMCKVEEVCOR
P/E now vs peer median 25.7xmedian 24.3x 50.9xmedian 42.4x 24.3xmedian 24.3x
P/S now vs peer median 0.3xmedian 0.3x 14.9xmedian 2.7x 0.2xmedian 0.3x
EV/EBITDA now vs peer median 16.6xmedian 13.5x 40.5xmedian 19.0x 17.5xmedian 13.5x
P/FCF now vs peer median 18.0xmedian 15.6x 30.9xmedian 19.4x 15.5xmedian 15.6x
P/B now vs peer median -27.3xmedian 2.5x 6.9xmedian 1.8x 19.5xmedian 2.5x
PEG now vs peer median 2.15median 1.33 2.22median 1.75 1.36median 1.33

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMCKVEEVCOR
Revenue $410.98B $3.46B $332.77B
Gross profit $14.96B $2.59B $13.22B
Operating income $6.50B $1.03B $3.04B
Net income $5.30B $1.01B $2.65B
Free cash flow $6.42B $1.67B $4.06B
R&D – $821.92M –
EPS (diluted) $38.52 $6.15 $13.53
Cash & equivalents $5.16B $1.81B $2.82B
Total debt $9.73B – $11.72B
Shares (diluted) 119.20M 165.06M 193.94M
Enterprise value $99.42B $23.06B $52.14B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMCKVEEVCOR
P/E 25.7x 50.9x 24.3x
P/FCF 18.0x 30.9x 15.5x
P/Operating cash flow 16.9x 30.9x 13.1x
P/S 0.3x 14.9x 0.2x
P/B -27.3x 6.9x 19.5x
P/Tangible book -14.0x 7.0x -23.4x
EV/EBITDA 16.6x 40.5x 17.5x
EV/EBIT 18.5x 42.8x 23.6x
EV/Revenue 0.3x 12.8x 0.2x
EV/FCF 18.8x 26.6x 17.7x
EV/Operating cash flow 17.6x 26.6x 14.9x
PEG (3Y EPS CAGR) 2.15 2.22 1.36

Growth

14 metrics
MetricMCKVEEVCOR
Revenue growth (1Y) 8.8% 16.5% 5.1%
Revenue CAGR (3Y) 13.1% 15.7% 9.4%
Gross profit growth (1Y) 11.2% 15.5% 20.0%
Gross profit CAGR (3Y) 6.6% 18.0% 15.0%
Operating income growth (1Y) 46.6% 29.5% 11.1%
Operating income CAGR (3Y) 13.5% 37.8% 9.5%
Net income growth (1Y) 58.1% 25.3% 38.9%
Net income CAGR (3Y) 10.7% 23.4% 16.2%
EPS growth (1Y) 52.8% 27.3% 39.3%
EPS CAGR (3Y) 12.0% 22.9% 17.9%
Operating cash flow growth (1Y) 4.7% 23.4% 176.7%
Operating cash flow CAGR (3Y) 10.7% 19.5% 14.1%
Free cash flow growth (1Y) 6.8% 23.4% 255.7%
Free cash flow CAGR (3Y) 11.3% 19.5% 13.3%

Profitability

14 metrics
MetricMCKVEEVCOR
Gross margin 3.6% 75.0% 4.0%
EBITDA margin 1.8% 31.6% 1.2%
Operating margin 1.6% 29.9% 0.9%
Pretax margin 1.6% 38.4% 1.1%
Net margin 1.1% 29.3% 0.8%
FCF margin 1.6% 48.2% 1.2%
Operating cash flow margin 1.7% 48.2% 1.4%
Return on equity – 13.8% 77.4%
Return on assets 6.2% 11.2% 3.2%
Return on invested capital 107.9% – 14.4%
Return on capital employed 43.4% 13.5% 12.9%
Asset turnover 4.8x 0.4x 4.0x
Cash conversion (OCF / net income) 1.3x 1.6x 1.8x
Stock comp / revenue – 14.3% 0.0%

Financial Health

11 metrics
MetricMCKVEEVCOR
Debt / assets 11.0% – 14.0%
Debt / equity -2.3x – 3.6x
Net debt / EBITDA 0.6x – 2.2x
Debt / FCF 1.5x – 2.9x
Liabilities / assets 104.8% 18.0% 96.1%
Equity / assets -4.8% 82.0% 3.9%
Interest coverage 23.6x – –
Current ratio 0.9x 5.5x 0.9x
Quick ratio 0.5x 5.4x 0.5x
Cash ratio 0.1x 5.0x 0.0x
Altman Z-score 5.90 21.35 4.66

Shareholder Returns

7 metrics
MetricMCKVEEVCOR
Dividend yield 0.3% – 0.7%
Net buyback yield 5.7% 0.7% 1.6%
Shareholder yield 6.1% 0.7% 2.3%
Payout ratio (earnings) 7.4% – 17.7%
Payout ratio (FCF) 6.1% – 11.5%
Dividend growth (1Y) 11.3% – 8.7%
Dividend CAGR (3Y) 10.0% – 5.7%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMCKVEEVCOR
Forward P/E 21.1xFY2026 35.5xFY2026 19.3xFY2026
EPS, next fiscal year $47.15FY2026 $8.97FY2026 $17.08FY2026
EPS growth, next FY +20.6%FY2026 +10.7%FY2026 +6.7%FY2026
EPS growth, the year after +11.0% +16.8% +11.8%
Revenue, next fiscal year $444.47BFY2026 $3.60BFY2026 $328.56BFY2026
Revenue growth, next FY +10.2%FY2026 +12.5%FY2026 +2.2%FY2026
Revenue growth, the year after +1.5% +17.3% -0.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMCKVEEVCOR
Held by institutions 89.1% 88.8% 94.7%
Institutions holding 2,007 1,056 1,342
Change in shares held, QoQ -0.7% +5.7% +15.7%
Institutions buying 879 586 542
Institutions selling 791 358 609
Buyers to sellers 1.11 1.64 0.89

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MCKVEEVCOR
MCK 1.00 -0.04 0.71
VEEV -0.04 1.00 0.00
COR 0.71 0.00 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MCK, VEEV and COR?

Mckesson (MCK) is the largest by market capitalisation: Mckesson (MCK) $115.52B, Veeva Systems (VEEV) $50.81B, Cencora (COR) $63.25B.

Which stock is cheaper, MCK, VEEV and COR?

Cencora (COR) trades on the lowest price-to-earnings ratio (Mckesson (MCK) 25.2x, Veeva Systems (VEEV) 50.1x, Cencora (COR) 24.1x). On next year's consensus earnings, Cencora (COR) is cheapest (Mckesson (MCK) 21.1x, Veeva Systems (VEEV) 35.5x, Cencora (COR) 19.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Veeva Systems (VEEV) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.8%, Veeva Systems (VEEV) +16.5%, Cencora (COR) +5.1%.

Which company is more profitable?

Veeva Systems (VEEV) has the highest net margin (Mckesson (MCK) 1.1%, Veeva Systems (VEEV) 29.3%, Cencora (COR) 0.8%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 107.9%, Cencora (COR) 14.4%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: Mckesson (MCK) +23.8%, Veeva Systems (VEEV) +8.6%, Cencora (COR) -0.7%. Over five years, Mckesson (MCK) compounded fastest (Mckesson (MCK) +37.4%/yr, Veeva Systems (VEEV) +0.3%/yr, Cencora (COR) +22.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Cencora (COR) has the highest dividend yield: Mckesson (MCK) 0.00%, Veeva Systems (VEEV) 0.00%, Cencora (COR) 0.01%. Veeva Systems (VEEV) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (Mckesson (MCK) 30.7%, Veeva Systems (VEEV) 42.9%, Cencora (COR) 32.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MCK, VEEV and COR?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.